We estimate that the CEO of Biohaven Ltd. ($BHVN), Vlad Coric, M.D., received a compensation of $13,500,438 in 2025. This is an increase of 22.38% from an estimated $10,479,038 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on March 13, 2026. Note that parsing errors may occur.
You can track $BHVN on Quiver Quantitative's $BHVN stock dashboard.
$BHVN Stock Insider Trading Activity
$BHVN Stock insiders have traded $BHVN stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $BHVN stock by insiders over the last 6 months:
- JOHN W CHILDS purchased 3,333,333 shares for an estimated $24,999,997
- VLAD CORIC (Chief Executive Officer) has made 2 purchases buying 666,666 shares for an estimated $4,999,995 and 0 sales.
- GREGORY BAILEY purchased 400,000 shares for an estimated $3,000,000
- GEORGE C. CLARK (VP, Chief Accounting Officer) purchased 17,000 shares for an estimated $144,770
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BHVN Stock Hedge Fund Activity
We have seen 184 institutional investors add shares of $BHVN Stock stock to their portfolio, and 140 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC removed 5,364,748 shares (-79.2%) from their portfolio in Q4 2025, for an estimated $60,568,004
- SUVRETTA CAPITAL MANAGEMENT, LLC added 4,666,666 shares (+83.0%) to their portfolio in Q4 2025, for an estimated $52,686,659
- TCG CROSSOVER MANAGEMENT, LLC added 4,631,317 shares (+inf%) to their portfolio in Q4 2025, for an estimated $52,287,568
- INFINITUM ASSET MANAGEMENT, LLC added 4,550,000 shares (+267.6%) to their portfolio in Q4 2025, for an estimated $51,369,499
- STIFEL FINANCIAL CORP added 3,328,506 shares (+50.3%) to their portfolio in Q4 2025, for an estimated $37,578,832
- BELLEVUE GROUP AG removed 2,802,853 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $31,644,210
- ARMISTICE CAPITAL, LLC removed 2,136,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $32,061,360
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BHVN Stock Analyst Ratings
Wall Street analysts have issued reports on $BHVN in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 01/06/2026
- JP Morgan issued a "Overweight" rating on 11/20/2025
- BTIG issued a "Buy" rating on 11/18/2025
- Citigroup issued a "Buy" rating on 11/13/2025
- TD Cowen issued a "Buy" rating on 11/05/2025
- UBS issued a "Buy" rating on 09/16/2025
To track analyst ratings and price targets for $BHVN Stock, check out Quiver Quantitative's $BHVN forecast page.
$BHVN Stock Price Targets
Multiple analysts have issued price targets for $BHVN recently. We have seen 9 analysts offer price targets for $BHVN in the last 6 months, with a median target of $15.0.
Here are some recent targets:
- Tyler Van Buren from TD Cowen set a target price of $30.0 on 03/11/2026
- Douglas Tsao from HC Wainwright & Co. set a target price of $10.0 on 03/04/2026
- Leonid Timashev from RBC Capital set a target price of $23.0 on 03/03/2026
- Terence Flynn from Morgan Stanley set a target price of $21.0 on 01/06/2026
- Ashwani Verma from UBS set a target price of $11.0 on 11/26/2025
- Tessa Romero from JP Morgan set a target price of $15.0 on 11/20/2025
- Thomas Shrader from BTIG set a target price of $16.0 on 11/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
